23 Mar 2018 | Leafly
Trying to keep track of all the advances in medical cannabis research? Here are some brief summaries of some of the biggest headlines over the last few months
17 Mar 2018 | mg Cannabis Retailer
The European Journal of Internal Medicine (EJIM) has published a special issue for March titled "Cannabis in Medicine."
16 Mar 2018 | Huntington's Disease News
MMJ BioScience has been licensed in Canada to produce cannabis-derived medicines for testing in FDA-approved studies for Huntington’s disease.
13 Mar 2018 | Neurology Advisor
Cannabinoids are effective as an adjunctive treatment for reducing seizure frequency in pediatric-onset treatment-resistant epilepsy.
8 Mar 2018 | European Pharmaceutical Review
Naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures,
6 Mar 2018 | Proactiveinvestors
Treatment with cannabinoid-based extracts could be an alternative to chemotherapy
27 Feb 2018 | Leafly
Dosage is the key factor in achieving the most benefits and least adverse effects of cannabis
22 Feb 2018 | Pharma Times
A mid-stage trial assessing an experimental cannabinoid being developed by GW Pharma for adults with focal seizures has failed to hit key targets.
22 Feb 2018 | The Inquirer Daily News
The Rothman Institute at Jefferson, one of the nation’s largest orthopedic practices, announced Thursday it would collaborate on a study to investigate the benefits of medical marijuana for patients suffering from chronic and acute pain.
21 Feb 2018 | MD Magazine
A recent study found that cannabis use is associated with a potentially beneficial reduction in systemic inflammation and immune activation in the context of antiretroviral therapy (ART)-treated HIV-infected individuals.